NCT07167836

Automated Clinical Pathway for Inflammatory Bowel Disease Care

Effect of an Automated Clinical Pathway Utilizing Tailored Risk Stratification on Rates of Overdue Follow up and Outcomes in Patients With Inflammatory Bowel Disease

• Status: Enrolling By Invitation
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,000 (estimated)
• Sponsor: University of Texas Southwestern Medical Center · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Pragmatic randomized controlled trial to evaluate the effect of an electronic medical record-based tool on improving on-time follow up and its effects on inflammatory bowel disease outcomes

Conditions

• Inflammatory Bowel Disease
• Inflammatory Bowel Disease (IBD)

Interventions

Type	Name	Description
OTHER	Electronic medical record-based care pathway	Participants will undergo initial automated risk stratification to direct tailored follow-up intervals. If exceeding the maximum time interval, participants in the intervention arm will be contacted by scheduling personnel using a standardized protocol to schedule a follow-up visit. In contrast, patients in the control arm who are overdue will not be made known to any staff and will not be proactively contacted, instead continuing to be managed according to standard of care. To maximize generalizability and understanding among staff and patients, risk stratification will be based on inflammatory bowel disease medication use.

Timeline

• Start date: 2025-12-12
• Primary completion: 2026-12-13
• Completion: 2026-12-13
• First posted: 2025-09-11
• Last updated: 2025-12-15

Locations

1 site across 1 country: United States